Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 1, 2007, Pages 1-5

  Blazek, Ed R ^a   Foutch, Jennifer L ^a   Maki, Guitta ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain tumor stem cell; CD133 (prominin 1) expression; Hypoxic response; Linear quadratic model and radiosensitivity; Medulloblastoma

Indexed keywords

BIOMARKERS; BRAIN; PATIENT TREATMENT; RADIOTHERAPY; TUMORS;

BRAIN TUMOR STEM CELL; CD133 (PROMININ-1) EXPRESSION; HYPOXIC RESPONSE; LINEAR-QUADRATIC MODEL AND RADIOSENSITIVITY; MEDULLOBLASTOMA;

CELLS;

CD133 ANTIBODY; CD133 ANTIGEN; CELL SURFACE PROTEIN; FLUORESCENT DYE; OXYGEN; TUMOR MARKER;

ALPHA CHAIN; ARTICLE; BETA CHAIN; CANCER STEM CELL; CELL CULTURE; CELL CYCLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; LINEAR QUADRATIC MODEL; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOBIOLOGY; RADIOSENSITIVITY; SERUM; STATISTICAL ANALYSIS; TUMOR CELL LINE;

ANTIGENS, CD; CELL CYCLE; CELL HYPOXIA; CEREBELLAR NEOPLASMS; GLYCOPROTEINS; HUMANS; MEDULLOBLASTOMA; OXYGEN; PEPTIDES; RADIATION TOLERANCE; TUMOR CELLS, CULTURED;

EID: 33845621982     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.09.037     Document Type: Article

References (15)

1. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
2. Miraglia S., Godfrey W., Yin A.H., et al. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 90 (1997) 5013-5021
3. Fan X., Matsui W., Khaki L., et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66 (2006) 7445-7452
4. Vindelov L.L., Christensen I.J., and Nissen N.I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3 (1983) 323-327
5. Grenman R., Burk D., Virolainen E., et al. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 44 (1989) 131-136
6. Lee J., Kotliarova S., Kotliarov Y., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9 (2006) 391-403
7. Ivanova N., Dobrin R., Lu R., et al. Dissecting self-renewal in stem cells with RNA interference. Nature 442 (2006) 533-538
8. Haraguchi N., Utsunomiya T., Inoue H., et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24 (2006) 506-513
9. Hamburger A.W., and Salmon S.E. Primary bioassay of human tumor stem cells. Science 197 (1977) 461-463
10. Chapman J.D. Single-hit mechanism of tumour cell killing by radiation. Int J Radiat Biol 79 (2003) 71-81
11. Gustafsson M.V., Zheng X., Pereira T., et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9 (2005) 617-628
12. Bao S., Wu Q., Sathornsumetee S., et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66 (2006) 7843-7848
13. Phillips H.S., Kharbanda S., Chen R., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9 (2006) 157-173
14. Blazek E.R. Mechanistic prediction of tumor control from pretreatment tumor volume, in vitro radiosensitivity, and cell kinetics parameters. In: Paliwal B.R., Fowler J.F., Herbert D.E., et al. (Eds). Volume and kinetics in tumor control and normal tissue complications (1998), Medical Physics Publishing, Madison 462-473
15. Frank N.Y., Margaryan A., Huang Y., et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65 (2005) 4320-4333